Psychotropic Drugs and ECG Changes: What Every Neuropsychiatry Resident Must Know

1. ECG Basics Relevant to Psychotropics

• PR interval (normal: 120-200 ms) - AV conduction time
• QRS duration (normal: <120 ms) - ventricular depolarization; widening = sodium channel blockade
• QT interval - ventricular depolarization + repolarization; must be corrected for heart rate
• QTc (corrected QT) - the key metric in psychiatry. Normal: <430 ms in men, <450 ms in women
• T wave - ventricular repolarization; lithium and antipsychotics affect this

QTc Correction Formulas

2. Mechanism of QTc Prolongation and TdP Risk

• QTc >500 ms - high risk; seriously consider stopping the offending drug
• Increase of >30 ms from baseline - requires increased monitoring
• Increase of >60 ms from baseline - cause for significant concern

Key Risk Factors That Amplify Drug-Induced QTc Prolongation

• Female sex (women have baseline longer QTc)
• Bradycardia
• Hypokalemia and hypomagnesemia
• Structural heart disease (HF, recent MI)
• Congenital long QT syndrome or Brugada syndrome (can be unmasked by psychotropics)
• Polypharmacy with other QTc-prolonging agents (antibiotics, antifungals, methadone, antiarrhythmics)
• Physical restraint (increases catecholamines, lowers K+ uptake)

3. Antipsychotics

First-Generation Antipsychotics (FGAs)

Second-Generation Antipsychotics (SGAs)

Key clinical rule: Thioridazine, ziprasidone, and iloperidone carry meaningfully elevated risk. Aripiprazole and lurasidone carry the lowest risk. When a cardiac-risk patient needs an antipsychotic, prefer these.

Clozapine and Myocarditis - A Separate ECG Concern

• ST-segment depression >1 mm in ≥2 contiguous leads (other than aVR)
• T-wave inversion in ≥2 contiguous leads

4. Tricyclic Antidepressants (TCAs)

• Prolonged PR interval (first-degree AV block)
• Widened QRS (>120 ms = sodium channel toxicity; this is the key marker in overdose)
• Prolonged QT interval
• ST-segment and T-wave abnormalities
• Tachycardia (from anticholinergic effects)

• QRS >100 ms: risk of seizures
• QRS >160 ms: high risk of ventricular arrhythmias
• Terminal R wave in lead aVR >3 mm - highly specific for TCA toxicity

• Any patient older than 40 years
• Any patient with known cardiovascular disease
• If QTc exceeds 440 ms, the patient is at increased risk for sudden cardiac death - Kaplan & Sadock's Synopsis

5. SSRIs and SNRIs

6. Mood Stabilizers

Lithium

• Displaces intracellular potassium, mimicking hypokalemia on ECG
• Most common ECG change: T-wave flattening or inversion - this is benign and reversible
• At toxic levels: SA node dysfunction, sinus bradycardia, sinoatrial block, heart block
• Lithium can unmask congenital long QT syndrome and Brugada syndrome
• Obtain baseline ECG if risk factors for CAD; ECG recommended before initiation in older patients
• T-wave changes are benign - do not panic; assess clinically and check lithium levels

Lamotrigine

• Sodium channel blocker (like TCAs/phenytoin); theoretical concern for cardiac conduction effects
• A 2022 systematic review (PMID 35763920) found the overall cardiac risk with lamotrigine to be low at therapeutic doses, but noted case reports of arrhythmia and conduction abnormalities in overdose
• Valproate: no significant direct ECG changes at therapeutic doses

7. Other Psychotropics

8. Drug-Drug Interactions

• Fluoxetine and paroxetine (strong CYP2D6 inhibitors) can dramatically increase levels of TCAs, risperidone, and other drugs
• Fluvoxamine (strong CYP1A2/2C19 inhibitor) raises clozapine and haloperidol levels
• Adding azithromycin, clarithromycin, fluoroquinolones, fluconazole, or ketoconazole to a patient already on a QTc-prolonging antipsychotic is a recognized risk

9. Practical ECG Monitoring Guide

10. Takotsubo Syndrome and Psychotropics

• Psychiatric patients (especially with severe anxiety, PTSD, or acute psychosis) are at risk
• SNRIs, bupropion, TCAs, MAOIs, and atomoxetine increase norepinephrine and may precipitate or worsen TTS
• Case reports link TTS to ECT (electroconvulsive therapy)
• Post-TTS, avoid medications that raise catecholamine levels when possible

Summary Table: QTc Risk by Drug Class

Latest Case Reports: QTc Prolongation in Neuropsychiatric Patients (PubMed, 2023-2026)

BONUS: 2025 Systematic Review (High-Priority Finding)

[Systematic Review · 2025] QT Interval Prolongation in Acute Antipsychotic Poisoning: Systematic Review and Recommendations

• Amisulpride, thioridazine, ziprasidone - highest QTc/TdP risk in overdose; continuous cardiac monitoring recommended for: amisulpride >2 g, thioridazine >1 g, ziprasidone >3 g
• Haloperidol, iloperidone, pimozide, pipamperone - cardiac monitoring suggested (lower confidence evidence)
• Quetiapine, olanzapine, risperidone - QTc risk likely overstated; no continuous cardiac monitoring recommended for quetiapine and olanzapine overdose specifically
• Clozapine - no recommendation for continuous monitoring for QTc (note: separate myocarditis risk still applies)
• ECG screening is recommended for ALL patients with acute antipsychotic overdose regardless of agent

Case Reports (2023-2026)

1. [Case Report · 2026] Anxiety Management in Myasthenia Gravis Crisis With QTc 563 ms

2. [Case Report · 2025] ECG Changes With Antipsychotic Use: Emergency Department Vignette

• Agitated patients in the ED are at elevated QTc risk because they often receive higher doses, and physical agitation increases catecholamines that further compound risk
• Both haloperidol and ziprasidone (the two most commonly used IV/IM antipsychotics in acute agitation) are QTc-prolonging
• The case emphasizes individualized ECG monitoring, electrolyte correction, and informed agent selection before dosing in the ED
• Highlights the importance of knowing a patient's baseline QTc before administering antipsychotics in the acute setting

3. [Case Report · 2025] Amisulpride Overdose → Bradycardia, QT Prolongation, and TdP

• Despite the >7-hour delay, the team performed gastroscopy with gastric lavage and activated charcoal - amisulpride plasma levels were measured before and after via LC-HRMS and confirmed a meaningful reduction post-lavage
• Temporary cardiac pacing was required
• Illustrates that gastric decontamination may still be beneficial even with delayed presentation in amisulpride overdose, given its severe and prolonged cardiac toxicity

4. [Case Report · 2025] Bradycardia + Prolonged QT in a Young Psychiatric Patient: How to Safely Give Antipsychotics

1. The Bazett formula (QTcB = 427 ms here) and Fridericia formula (QTcF = 448 ms here) gave different values - demonstrates why formula choice matters, especially in bradycardia
2. Not all patients with a prolonged QT + bradycardia are absolutely contraindicated for antipsychotics - risk stratification and close monitoring can allow safe treatment
3. Standalone psychiatric facilities without cardiology access need a structured decision framework; this paper offers one
4. Valproate does not independently prolong QTc - a useful combination partner in these cases

5. [Case Report · 2024] Polypharmacy-Induced QT Prolongation in Advanced Cancer: Methadone + Haloperidol + Fluoxetine

• Palliative care patients frequently receive all three of these agents simultaneously: methadone (pain/opioid use), haloperidol (delirium/nausea), fluoxetine (depression/anxiety)
• Each agent independently prolongs QTc; the combination is a triple hit
• Fluoxetine here also contributes a pharmacokinetic interaction - it inhibits CYP2D6, which metabolizes haloperidol, raising haloperidol plasma levels further
• QT prolongation was reversible after medication review and adjustment
• Emphasizes the need for a systematic medication review in any medically complex patient before adding psychotropics

6. [Case Report · 2026] Dexmedetomidine in Agitated Elderly Patient With QTc Prolongation Limiting Antipsychotic Use

Summary Table